Jazz Pharmaceuticals (JAZZ) announces plans for underwritten public offering of 5.375M shares of its stock held by certain shareholders. JAZZ will not receive any proceeds from the offering. Barclays is acting as sole book-running manager for the offering. Shares -2.1% AH.
Are you Bullish or Bearish on ?
Sentiment on ()
Thanks for sharing your thoughts.